This book includes a plain text version that is designed for high accessibility. To use this version please follow this link.
11-08 :: August 2011


nanotimes


Companies Facts


2011 third quarter ended June 30, 2011. No reve- nue was recorded for the three months ended June 30, 2011 and 2010. Total operating expenses for the quarter ended June 30, 2011 were $1.8 million, compared with $1.4 million for the quarter ended June 30, 2010. The increase in operating expenses was primarily due to increased outside lab ser- vices and contract services to support enrollment in Calando’s clinical trial and increased costs related to foreign patent filings and attorney fees associa- ted with Calando’s intellectual property portfolio. Loss from continuing operations attributable to Arrowhead for the fiscal 2011 third quarter was $1.9 million, or ($0.03) per share, compared with income of $84 thousand, or $0.00 per share in the compara- ble period in fiscal 2010.


A


Total net loss attributable to Arrowhead for the quar- ter ended June 30, 2011, which includes discontinu- ed operations, was $1.8 million, or ($0.03) per share based on 71.8 million weighted average shares out- standing. This compares with a total net loss attribu- table to Arrowhead of $371 thousand, or ($0.01) per share based on 64.6 million weighted average shares outstanding, for the quarter ended June 30, 2010.


http://www.arrowheadresearch.com a


ustriamicrosystems (SIX:AMS) has announced the AS1328 high-efficiency 1.5 MHz synchronous


DC-DC step-down converter. This buck regulator features efficiencies up to 96%, excellent light load efficiencies and with a quiescent current of only 25 μA. The AS1328 can deliver up to 3A of output cur-


T


he Bruker Nano Surfaces division (Bruker Cor- poration, NASDAQ: BRKR) has been selected


for an R&D 100 Award for AcuityXR™ enhanced- resolution microscopy technology. This novel opti- cal surface profiler mode combines patent-pending hardware and software to enable select models of


rrowhead Research Corporation (NASDAQ: ARWR) announced financial results for its fiscal


rent at output voltages as low as 0.6 V while opera- ting from an input voltage of 2.7 to 5.5 V over a -40° C to 85° C (-40° F to 185° F) temperature range.


http://www.austriamicrosystems.com/DC-DC/AS1328 I


n his National Day Rally speech, Lee Hsien Loong, Prime Minister of Singapore, expressly mentioned


Nanostart (OTCQX: NASRY) holding BioMers as an example of a successful start-up company set up by students of the National University of Singapore (NUS). “The success story of the local start-up behind the world’s first translucent dental braces shows why it is important to have a good mix of local and fo- reign students in universities here”, said the premier.


BioMers has already obtained approval for its pro- ducts in the USA, the European Union and various countries in Asia, and is in the process of marketing its products internationally. The Nanostart Singapore Early Stage Venture Fund, which Nanostart holds in conjunction with the government of Singapore, has a 24.7% stake in BioMers.


http://www.nanostart.de http://www.biomersbraces.com


21


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103